Terms: = Leukemia AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
12 results:
1. Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma.
Yasunaga JI
Int J Hematol; 2023 Apr; 117(4):504-511. PubMed ID: 36705848
[TBL] [Abstract] [Full Text] [Related]
2. Malignant Progression of an Ancestral Bone Marrow Clone Harboring a cic-NUTM2A Fusion in Isolated Myeloid Sarcoma.
Kamens JL; Dang J; Shaw TI; Gout AM; Newman S; Hagiwara K; Smith AMR; Obermayer AN; Aldridge S; Ma J; Zhang Y; Wu G; Leventaki V; Santiago T; Raimondi S; Nakitandwe J; Pappo A; Li C; Zhang J; Gruber TA
Mol Cancer Res; 2023 Apr; 21(4):301-306. PubMed ID: 36637394
[TBL] [Abstract] [Full Text] [Related]
3. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.
Ueno H; Yoshida K; Shiozawa Y; Nannya Y; Iijima-Yamashita Y; Kiyokawa N; Shiraishi Y; Chiba K; Tanaka H; Isobe T; Seki M; Kimura S; Makishima H; Nakagawa MM; Kakiuchi N; Kataoka K; Yoshizato T; Nishijima D; Deguchi T; Ohki K; Sato A; Takahashi H; Hashii Y; Tokimasa S; Hara J; Kosaka Y; Kato K; Inukai T; Takita J; Imamura T; Miyano S; Manabe A; Horibe K; Ogawa S; Sanada M
Blood Adv; 2020 Oct; 4(20):5165-5173. PubMed ID: 33095873
[TBL] [Abstract] [Full Text] [Related]
4. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
[TBL] [Abstract] [Full Text] [Related]
5. 5-Nitro-2-(3-phenylpropylamino) benzoic acid induced drug resistance to cisplatin in human erythroleukemia cell lines.
Xu Y; Zheng H; Kang JS; Zhang L; Su J; Li HY; Sun LK
Anat Rec (Hoboken); 2011 Jun; 294(6):945-52. PubMed ID: 21538933
[TBL] [Abstract] [Full Text] [Related]
6. Impact of intensity of conditioning therapy in patients aged 40-60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation.
Khabori MA; El-Emary M; Xu W; Guyatt G; Galal A; Kuruvilla J; Lipton J; Messner H; Gupta V
Bone Marrow Transplant; 2011 Apr; 46(4):516-22. PubMed ID: 20622907
[TBL] [Abstract] [Full Text] [Related]
7. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
Larson RA; Lukin CL; Daly KM; Mick R; Gore S; Le Beau MM
Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
[TBL] [Abstract] [Full Text] [Related]
8. Circulating immune complexes in patients with hematologic diseases.
Yen JH; Liu HW; Lin SF; Chen TP; Chang CS; Liu TC; Tsai WJ
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):138-44. PubMed ID: 2605974
[TBL] [Abstract] [Full Text] [Related]
9. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract] [Full Text] [Related]
10. Circulating immune complexes in childhood malignancies: a Pediatric Oncology Group study.
Castleberry RP; Duncan MR; Stagno S; Fernbach DJ; Land V
J Clin Oncol; 1983 Dec; 1(12):799-803. PubMed ID: 6583317
[TBL] [Abstract] [Full Text] [Related]
11. Circulating immune complexes in chronic myeloid leukemia: turbidimetric measurement and two-dimensional electrophoretic analysis.
Chhajlani V; Zingde S; Adwani S; Gothoskar B
Leuk Res; 1983; 7(5):565-73. PubMed ID: 6580515
[TBL] [Abstract] [Full Text] [Related]
12. Serial complement measurements in patients with leukaemia.
Minh DQ; Czink E; Mód A; Füst G; Hollan SR
Clin Lab Haematol; 1983; 5(1):23-34. PubMed ID: 6552202
[TBL] [Abstract] [Full Text] [Related]
